West Pharmaceutical Services Long-Term Investments 2010-2024 | WST

West Pharmaceutical Services long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • West Pharmaceutical Services long-term investments for the quarter ending December 31, 2024 were $0.202B, a 3.76% decline year-over-year.
  • West Pharmaceutical Services long-term investments for 2024 were $0.202B, a 3.76% decline from 2023.
  • West Pharmaceutical Services long-term investments for 2023 were $0.21B, a 2.49% increase from 2022.
  • West Pharmaceutical Services long-term investments for 2022 were $0.205B, a 1.35% decline from 2021.
West Pharmaceutical Services Annual Long-Term Investments
(Millions of US $)
2024 $202
2023 $210
2022 $205
2021 $208
2020 $215
2019 $193
2018 $91
2017 $86
2016 $83
2015 $61
2014 $61
2013 $61
2012 $60
2011 $56
2010 $48
2009 $38
West Pharmaceutical Services Quarterly Long-Term Investments
(Millions of US $)
2024-12-31 $202
2024-09-30 $218
2024-06-30 $198
2024-03-31 $203
2023-12-31 $210
2023-09-30 $195
2023-06-30 $203
2023-03-31 $209
2022-12-31 $205
2022-09-30 $189
2022-06-30 $193
2022-03-31 $208
2021-12-31 $208
2021-09-30 $216
2021-06-30 $212
2021-03-31 $212
2020-12-31 $215
2020-09-30 $210
2020-06-30 $200
2020-03-31 $198
2019-12-31 $193
2019-09-30 $97
2019-06-30 $95
2019-03-31 $95
2018-12-31 $91
2018-09-30 $91
2018-06-30 $92
2018-03-31 $90
2017-12-31 $86
2017-09-30 $85
2017-06-30 $84
2017-03-31 $81
2016-12-31 $83
2016-09-30 $81
2016-06-30 $78
2016-03-31 $62
2015-12-31 $61
2015-09-30 $59
2015-06-30 $60
2015-03-31 $59
2014-12-31 $61
2014-09-30 $62
2014-06-30 $60
2014-03-31 $59
2013-12-31 $61
2013-09-30 $59
2013-06-30 $58
2013-03-31 $56
2012-12-31 $60
2012-09-30 $61
2012-06-30 $58
2012-03-31 $58
2011-12-31 $56
2011-09-30 $55
2011-06-30 $51
2011-03-31 $49
2010-12-31 $48
2010-09-30 $44
2010-06-30 $40
2010-03-31 $40
2009-12-31 $38
2009-09-30 $36
2009-06-30 $34
2009-03-31 $36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.596B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65